Login Register Cart 0
Generic placeholder image

Current Aging Science

Editor-in-Chief

ISSN (Print): 1874-6098
ISSN (Online): 1874-6128

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

COVID-19 and Brain Aging: What are the Implications of Immunosenescence?

Author(s): Gabriela Serafim Keller, Eduarda Behenck Medeiros, Maria Laura Cecconi dos Santos, Adrielly Vargas Lidio, Ewa Kucharska and Josiane Budni*

Volume 16, Issue 2, 2023

Published on: 24 February, 2023

Page: [89 - 96] Pages: 8

DOI: 10.2174/1874609816666221228103320

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

The human lifespan is increasing, and mankind is aging. It is estimated that, until the year 2050, this population worldwide will reach 22% of the total world population. Along with aging, the human immunologic system changes, a process called immunosenescence or even inflammaging. The aging immune system increases mortality and morbidity in the elderly mainly because it loses its capacity to react against internal and external aggressions. There is a decrease in B and T lymphocytes and CD4+ lymphocytes lose the CD28 protein expression that is needed for costimulation, leading to reduced response to viral infections. This could be responsible for more deleterious consequences of coronavirus disease infection in the elderly. Besides that, the human brain ages, being more susceptible to damage and viral infections, such as COVID-19 infection. There are several pathways that could explain the susceptibility to the COVID-19 infection in the elderly brain, one of them is binding to ACE 2 receptors in cerebral cells through the spike protein. It has been reported that glial cells and neurons, in addition to endothelial and arterial smooth muscle cells in the brain, express the ACE 2 receptor, which would justify the neurological symptoms and consequences of the disease. This infection can have several clinical manifestations such as hemorrhagic stroke, delirium and long-term cognitive complaints, such as brain fog, polyneuropathies, short time memory complaints and insomnia. Although none of the studies could prove that there is a long-term neuronal damage, there are clinical sequelae that should be taken into account and more studies are necessary to know the consequences of the infection in the elderly brain.

Keywords: COVID-19, SARS-CoV-2, aging, immunosenescence, inflammaging, cognition, brain.

« Previous
Graphical Abstract

[1]
Pan American Health Organization. Healthy ageing. Available from: https://www.paho.org/pt/topicos/envelhecimento-saudavel
[2]
Daniele S, Giacomelli C, Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management. Biochem Pharmacol 2018; 158: 207-16.
[http://dx.doi.org/10.1016/j.bcp.2018.10.030] [PMID: 30393045]
[3]
Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature 2016; 539(7628): 180-6.
[http://dx.doi.org/10.1038/nature20411] [PMID: 27830812]
[4]
Button EB, Robert J, Caffrey TM, Fan J, Zhao W, Wellington CL. HDL from an alzheimer's disease perspective. Curr Opin Lipidol 2019; 30(3): 224-34.
[http://dx.doi.org/10.1097/MOL.0000000000000604] [PMID: 30946049]
[5]
Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57(2): 178-201.
[http://dx.doi.org/10.1016/j.neuron.2008.01.003] [PMID: 18215617]
[6]
Lopez A, Lee SE, Wojta K, et al. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain 2017; 140(4): 1128-46.
[http://dx.doi.org/10.1093/brain/awx005] [PMID: 28334843]
[7]
Mattson MP, Arumugam TV. Hallmarks of brain aging: Adaptive and pathological modification by metabolic states. Cell Metab 2018; 27(6): 1176-99.
[http://dx.doi.org/10.1016/j.cmet.2018.05.011] [PMID: 29874566]
[8]
Madabhushi R, Pan L, Tsai LH. DNA damage and its links to neurodegeneration. Neuron 2014; 83(2): 266-82.
[http://dx.doi.org/10.1016/j.neuron.2014.06.034] [PMID: 25033177]
[9]
Fulop T, Larbi A, Hirokawa K, Cohen AA, Witkowski JM. Immunosenescence is both functional/adaptive and dysfunctional/maladaptive. Semin Immunopathol 2020; 42(5): 521-36.
[http://dx.doi.org/10.1007/s00281-020-00818-9] [PMID: 32930852]
[10]
Barbé-Tuana F, Funchal G, Schmitz CRR, Maurmann RM, Bauer ME. The interplay between immunosenescence and age-related diseases. Semin Immunopathol 2020; 42(5): 545-57.
[http://dx.doi.org/10.1007/s00281-020-00806-z] [PMID: 32747977]
[11]
Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: Age-related diseases or longevity? Ageing Res Rev 2021; 71: 101422.
[http://dx.doi.org/10.1016/j.arr.2021.101422] [PMID: 34391943]
[12]
Witkowski JM, Fulop T, Bryl E. Immunosenescence and COVID-19. Mech Ageing Dev 2022; 204: 111672.
[http://dx.doi.org/10.1016/j.mad.2022.111672] [PMID: 35378106]
[13]
Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of senescence and aging in sars-cov-2 infection and COVID-19 disease. Cells 2021; 10(12): 3367.
[http://dx.doi.org/10.3390/cells10123367] [PMID: 34943875]
[14]
Pawelec G. Age and immunity: What is “immunosenescence”? Exp Gerontol 2018; 105: 4-9.
[http://dx.doi.org/10.1016/j.exger.2017.10.024] [PMID: 29111233]
[15]
Frasca D, Diaz A, Romero M, Garcia D, Blomberg BB. B cell immunosenescence. Annu Rev Cell Dev Biol 2020; 36(1): 551-74.
[http://dx.doi.org/10.1146/annurev-cellbio-011620-034148] [PMID: 33021823]
[16]
Delves PJ, Martin SJ, Burton DR. IM Fundamentals of immunology. 2018.
[17]
Ventura MT, Casciaro M, Gangemi S, Buquicchio R. Immunosenescence in aging: Between immune cells depletion and cytokines up-regulation. Clin Mol Allergy 2017; 15(1): 21.
[http://dx.doi.org/10.1186/s12948-017-0077-0] [PMID: 29259496]
[18]
World Health Organizarion. Weekly epidemiologycal update in COVID 19. 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-COVID-19---29-june-2021
[19]
Şı̇mşek Yavuz S, Komşuoğlu Çelı̇kyurt İ. An update of anti-viral treatment of COVID-19. Turk J Med Sci 2021; 51(SI-1): 3372-90.
[http://dx.doi.org/10.3906/sag-2106-250] [PMID: 34391321]
[20]
Kumar D, Jahan S, Khan A, et al. Neurological manifestation of sars-cov-2 induced inflammation and possible therapeutic strategies against COVID-19. Mol Neurobiol 2021; 58(7): 3417-34.
[http://dx.doi.org/10.1007/s12035-021-02318-9] [PMID: 33715108]
[21]
Verkhratsky A, Li Q, Melino S, Melino G, Shi Y. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct 2020; 15(1): 28.
[http://dx.doi.org/10.1186/s13062-020-00282-3] [PMID: 33246479]
[22]
Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 2020; 267(8): 2179-84.
[http://dx.doi.org/10.1007/s00415-020-09929-7] [PMID: 32458193]
[23]
Rizzo MR, Paolisso G. SARS-CoV-2 emergency and long-term cognitive impairment in older people. Aging Dis 2021; 12(2): 345-52.
[http://dx.doi.org/10.14336/AD.2021.0109] [PMID: 33815868]
[24]
Fifi JT, Mocco J. COVID-19 related stroke in young individuals. Lancet Neurol 2020; 19(9): 713-5.
[http://dx.doi.org/10.1016/S1474-4422(20)30272-6] [PMID: 32822622]
[25]
Najjar S, Najjar A, Chong DJ, et al. Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020; 17(1): 231.
[http://dx.doi.org/10.1186/s12974-020-01896-0] [PMID: 32758257]
[26]
Brouwer MC, Ascione T, Pagliano P. Neurologic aspects of COVID-19: A concise review. Infez Med 2020; 28(S1): 42-5.
[PMID: 32532937]
[27]
Khaddaj-Mallat R, Aldib N, Bernard M, et al. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein. Neurobiol Dis 2021; 161: 105561.
[http://dx.doi.org/10.1016/j.nbd.2021.105561] [PMID: 34780863]
[28]
Maiese A, Manetti AC, Bosetti C, et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol 2021; 31(6): e13013.
[http://dx.doi.org/10.1111/bpa.13013] [PMID: 34390282]
[29]
Wittock E, Van Den Bossche MJA. Delirium as the only symptom COVID-19 pneumonia in the elderly (Delirium as the only symptom of COVID-19 pneumonia in the elderly). Tijdschr Psychiatr 2020; 62(12): 1014-9.
[PMID: 33443753]
[30]
Low B, Xian NQQ, Brooks I, Heller A, Daher B, Dani M. Delirium in older inpatients with COVID-19: Impact on service provision. Future Healthc J 2021; 8(3): e689-91.
[http://dx.doi.org/10.7861/fhj.2021-0017] [PMID: 34888467]
[31]
Duggan MC, Van J, Ely EW. Delirium assessment in critically ill older adults. Crit Care Clin 2021; 37(1): 175-90.
[http://dx.doi.org/10.1016/j.ccc.2020.08.009] [PMID: 33190768]
[32]
Mattison MLP. Delirium. Ann Intern Med 2020; 173(7): ITC49-64.
[http://dx.doi.org/10.7326/AITC202010060] [PMID: 33017552]
[33]
Maeker É, Maeker-Poquet B. Acute confusion, a possible typical presentation of COVID-19 in the elderly. Soins Gerontol 2021; 26(149): 10-5.
[http://dx.doi.org/10.1016/j.sger.2021.03.003] [PMID: 34083008]
[34]
Wang H, Tang X, Fan H, et al. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients. Aging 2020; 12(11): 10022-34.
[http://dx.doi.org/10.18632/aging.103335] [PMID: 32527987]
[35]
Mattioli F, Stampatori C, Righetti F, Sala E, Tomasi C, De Palma G. Neurological and cognitive sequelae of COVID-19: A four month follow-up. J Neurol 2021; 268(12): 4422-8.
[http://dx.doi.org/10.1007/s00415-021-10579-6] [PMID: 33932157]
[36]
Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci 2022; 434: 120162.
[http://dx.doi.org/10.1016/j.jns.2022.120162] [PMID: 35121209]
[37]
Alonso-Lana S, Marquié M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front Aging Neurosci 2020; 12: 588872.
[http://dx.doi.org/10.3389/fnagi.2020.588872] [PMID: 33192483]

Rights & Permissions Print Cite
Article Metrics
39
2
Wayfinder Image
Open Access Journals Promotions
International Day of People with Disability
© 2024 Bentham Science Publishers | Privacy Policy